If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.40 (0.62%)
Bid:
64.20
Ask:
66.80
Spread: 2.60 (4.05%)
Market Cap: £112.42m
GABI Live PriceLast checked at - London Stock Exchange

Intraday Gcp Asset Bckd Share Chart

Proposed C Share Issue

5 Jan 2017 13:48

RNS Number : 4665T
GCP Asset Backed Income Fund Ltd
05 January 2017
 

GCP Asset Backed Income Fund Limited (the "Company" or "GCP Asset Backed Income")

Proposed C Share issue

On 8 November 2016 GCP Asset Backed Income announced the results of a substantially oversubscribed placing of ordinary shares in November 2016, raising gross proceeds of c.£15.6 million (the "Placing"). The net proceeds of the Placing have now been substantially invested or committed for investment.

In light of the attractive pipeline of investment opportunities identified by the Investment Manager, Gravis Capital Partners LLP, in the near term, and the premium rating of its shares in the secondary market, the Board of GCP Asset Backed Income is considering increasing the Company's capital base through a pre-emptive offer of c shares at a price of 100 pence per c share and targeting gross proceeds of £100 million (the "Issue").

The Issue is expected to broaden the Company's investor base, improve secondary market liquidity for shareholders, reduce its ongoing charges ratio per ordinary share by providing a larger equity base over which its fixed costs are spread and further diversify its portfolio of investments.

The Company is taking legal, tax and financial advice and will make a further announcement in due course.

Any issue of c shares will be subject to the approval of a prospectus in connection with the Issue by the UK Listing Authority.

Expected timetable:

+44 (0)20 7518 1490

Publication of Prospectus in connection with the Issue

late January 2017

Issue close and Admission

mid February 2017

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

For further information, please contact:

Gravis Capital Partners LLP

+44 (0)20 7518 1490

David Conlon

david.conlon@gcpuk.com

Philip Kent

 

Dion Di Miceli

philip.kent@gcpuk.com

 

dion.dimiceli@gcpuk.com

Cenkos Securities plc

+44 (0)20 7397 8900

Tom Scrivens

tscrivens@cenkos.com

Oliver Packard

opackard@cenkos.com

Sapna Shah

sshah@cenkos.com

Buchanan

+44 (0)20 7466 5000

Charles Ryland

charlesr@buchanan.uk.com

Victoria Hayns

victoriah@buchanan.uk.com

 

Notes to Editors

The Company

GCP Asset Backed Income is a closed ended investment company traded on the London Stock Exchange's main market for listed securities. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective through a diversified portfolio of investments secured against contracted, predictable medium to long term cash flows and/or physical assets which are predominantly UK based

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKPDQNBKDADK
Date   Source Headline
14th Aug 20177:00 amRNSNew social infrastructure investment
10th Aug 20177:00 amRNSScrip Share Reference Price
7th Aug 201711:38 amRNSHolding(s) in Company
2nd Aug 201711:58 amRNSInvestor Report 30 June 2017
1st Aug 201711:18 amRNSTotal Voting Rights & Additional Listing
28th Jul 20177:00 amRNSConversion of C shares
27th Jul 20177:00 amRNSDividend Declaration & Scrip Dividend Alternative
18th Jul 20177:00 amRNSNet Asset Value(s)
18th Jul 20177:00 amRNSConversion of C Shares
27th Jun 20171:37 pmRNSNew Investments
9th Jun 20179:47 amRNSNew Investment
2nd Jun 20172:54 pmRNSNew investment
30th May 201711:31 amRNSNew investment
23rd May 201712:28 pmRNSResult of AGM
2nd May 20179:25 amRNSInvestor Report as at 31 March 2017
25th Apr 20171:06 pmRNSDividend Declaration
24th Apr 20174:25 pmRNSAnnual General Meeting
20th Apr 20179:32 amRNSNovation of investment management agreement
19th Apr 20177:00 amRNSNet Asset Value(s)
13th Apr 20177:00 amRNSAnnual Report & Financial Statements
7th Apr 201712:36 pmRNSNew Directorship Notification
24th Mar 20177:00 amRNSInvestment commitment of £7 million
10th Mar 20172:55 pmRNSInvestment commitment of £17.5 million
2nd Mar 20172:26 pmRNSHolding(s) in Company
1st Mar 201710:37 amRNSTotal Voting Rights
15th Feb 20174:46 pmRNSHolding(s) in Company
10th Feb 201711:46 amRNSResult of OO, Placing & OFS
8th Feb 20173:39 pmRNSCorrection to Prospectus
25th Jan 20174:46 pmRNSInvestor Report as at 31 December 2016
25th Jan 20179:44 amRNSNon-Mainstream Pooled Investments
20th Jan 20174:05 pmRNSC Share Issue and Publication of Prospectus
18th Jan 20173:55 pmRNSDividend Declaration
13th Jan 20173:22 pmRNSNet Asset Value(s)
13th Jan 20171:39 pmRNSRevolving Credit Facility and further investment
5th Jan 20171:48 pmRNSProposed C Share Issue
23rd Dec 201612:48 pmRNSSocial infrastructure investments of £13.5 million
16th Dec 201611:27 amRNSInvestment commitment of £15.0 million
13th Dec 20163:48 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSTotal Voting Rights
21st Nov 201611:18 amRNSHolding(s) in Company
11th Nov 20163:14 pmRNSHolding(s) in Company
9th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 20167:00 amRNSResult of Placing
2nd Nov 20167:00 amRNSPlacing of New Ordinary Shares
25th Oct 201612:41 pmRNSInvestor Report as at 30 September 2016
20th Oct 20164:19 pmRNSHolding(s) in Company
19th Oct 20161:05 pmRNSReplacement Dividend Declaration
19th Oct 201612:56 pmRNSProposed Equity Raise
19th Oct 201612:51 pmRNSDividend Declaration
18th Oct 20168:00 amRNSTotal Voting Rights & Additional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.